Argos Therapeutics, Inc. (ARGS)

Country: United States of AmericaSector: HealthcareIndustry: BiotechnologyExchange: NASDAQ

Current price

0.27 USD-4.99%

Last close 24 Apr 2018

Interval

Benchmarks

Key financial summary

Financials in USD

		2012	2013	2014	2015	2016	2017
Total revenue	$m	-	-	2	1	1	2
Operating profit	$m						-62
Net profit	$m	-	-	-53	-75	-53	-41
EPS reported	$						-1.43
Operating cashflow per share	$						-
Capex per share	$						-
FCF per share	$						-
Free cash flow	$m						-39
Net debt	$m						-4
Book value equity	$m						-9
Book value per share	$						-0.33
Number of shares	m						28.32
DPS (TTM paid)	$						0.00

Financial summary

Financials in USD

		2017
Value
P/E TTM	x	-
P/B LTM	x	-0.16
P/S LTM	x	0.76
P/FCF LTM	x	-0.04
EV/EBITDA LTM	x	0.08
EV/Sales LTM	x	-
Earnings Yield LTM	%	-
FCF Yield	%	-2713.1%
Quality
ROE	%	-
ROIC	%	-
Operating margin	%	-
Gross margin	%	-
FCF/Sales	%	-
Growth and momentum
EPS Growth YoY	%	-
Sales Growth YoY	%	+100.90%
Net Income Growth YoY	%	-
FCF Growth	%	-
Operating Profit Growth	%	-
Dividend and capital structure
Dividend Yield	%	-
Dividend Growth	%	0.00%
Payout Ratio	%	-
FCF/Debt	x	-3.62
Net Debt/EBITDA	x	-
EBIT/Net interest	x	-
Net debt/market cap	%	-304.32%
Net debt/Equity	x	0.47
Gross debt/equity	x	-1.17

Company overview

No description available.

WebsiteN/A

SectorHealthcare

IndustryBiotechnology

CountryUnited States of America

Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Argos Therapeutics, Inc. (ARGS)

ARGS · NASDAQ · Healthcare

0.27 USD-4.99%

Benchmarks

Financialsin USD

20162017

Total revenue $m12

Operating profit $m-62

Net profit $m-53-41

EPS reported $-1.43

About